Active pulse blood constituent monitoring
AssigneeMasimo Laboratories, Inc.
InventorsEsmaiel Kiani-Azarbayjany, Mohamed Kheir Diab, James M. Lepper, Jr.
Life of this patent
Estimating the term…
Loading patent…
AssigneeMasimo Laboratories, Inc.
InventorsEsmaiel Kiani-Azarbayjany, Mohamed Kheir Diab, James M. Lepper, Jr.
Estimating the term…
A blood constituent monitoring method for inducing an active pulse in the blood volume of a patient. The induction of an active pulse results in a cyclic, and periodic change in the flow of blood through a fleshy medium under test. By actively inducing a change of the blood volume, modulation of the volume of blood can be obtained to provide a greater signal to noise ratio. This allows for the detection of constituents in blood at concentration levels below those previously detectable in a non-invasive system. Radiation which passes through the fleshy medium is detected by a detector which generates a signal indicative of the intensity of the detected radiation. Signal processing is performed on the electrical signal to isolate those optical characteristics of the electrical signal due to the optical characteristics of the blood.
A system for non-invasively monitoring concentrations of blood constituents in a living subject, said system comprising:
A method of non-invasively monitoring concentrations of blood constituents in a living subject, said method comprising:
A method of non-invasively monitoring glucose concentrations in a living subject, said method comprising:
A system for non-invasively monitoring concentrations of blood constituents in a living subject, said system comprising:
A method of non-invasively monitoring concentrations of blood constituents in a living subject, said method comprising:
A method of non-invasively monitoring glucose concentrations in a living subject, said method comprising:
Dependencies are inferred from the claim text.